The Diagnosis: Investors, Corporate Execs, and Regulators Sound Off On Medical Device Innovation https://t.co/sFqXdgntZD
— The Propell Group (@ThePropellGroup) October 23, 2016
#healthtech
The Diagnosis: Investors, Corporate Execs, and Regulators Sound Off On Medical Device Innovation https://t.co/sFqXdgntZD
— The Propell Group (@ThePropellGroup) October 23, 2016
#healthtech